Tissue microarrays: A practical guide

Pathology

Volumn 36, Issue 4, 2004, Pages 295-300

  Kumar, Beena ^a,b   De Silva, Melanie ^a,b   Venter, Deon J ^b,c   Armes, Jane E ^a,b,d  

^a Vic Breast Cancer Res Consortium   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Immunohistochemistry; in situ hybridisation; Tissue microarrays

Indexed keywords

DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; INFORMATION PROCESSING; MICROTOME; REVIEW; STAINING; TECHNIQUE; TISSUE CHARACTERIZATION; TISSUE MICROARRAY; TISSUE SECTION;

EID: 4444339084     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020410001721555     Document Type: Article

References (22)

1. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high throughput molecular profiling of tumour specimens. Nat Med 1998; 4: 844-7.
2. Packeisen J, Korsching E, Herbst H, et al. Demystified...tissue microarray technology. Mol Pathol 2003; 56: 198-204.
3. Milanes-Yearsley M, Hammond E, Pajak T, et al. Tissue micro-array: A cost and time effective method for correlative studies by regional and national cancer study groups. Mod Pathol 2002; 15: 1366-73.
4. Jensen TA, Hammond MEH. The tissue microarray - a technical guide for histologists. J Histotechnol 2001; 24: 283-7.
5. Coates A. International Breast Cancer Study Group trials. Recent Results Cancer Res 1998; 152; 429-40.
6. Colleoni M, Bonetti M, Coates AS, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumours not expressing oestrogen receptors. J Clin Oncol 2000; 18: 584-90.
7. Underwood J, Lowe D, editors. Recent Advances in Histopathology: 20. London: Royal Society of Medicine Press, 2003; Chapter 6, Tissue arrays: construction and applications.
8. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumours. Am J Pathol 2001; 158: 1245-51.
9. Sauter G, Mirlacher M. Tissue microarrays for predictive molecular pathology. J Clin Pathol 2002; 55: 575-6.
10. Horvath L, Henshall S. The application of tissue microarrays to cancer research. Pathology 2001; 33: 125-9.
11. Rubin MA, Dunn R, Strawderman M, et al. Tissue microarray sampling strategy for prostrate cancer biomarker analysis. Am J Surg Pathol 2002; 26: 312-9.
12. Mucci NR, Akdas G, Manely S, et al. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogenous protein expression. Hum Pathol 2000; 31: 406-14.
13. Simon R, Sauter G. Tissue microarrays for miniaturized high-throughput molecular profiling of tumours. Exp Hematol 2002; 30: 1365-72.
14. Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001; 159: 2249-56.
15. Camp RL, Charette LA, Rimm DL, et al. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000; 80: 1943-9.
16. Bubendorf L, Nocito A, Moch H, et al. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001; 195: 72-9.
17. Nocito A, Kononen J, Kallioniemi OP, et al. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001; 94: 1-5.
18. Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 2001; 81: 1331-8.
19. Scraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumour types. Clin Cancer Res 1999; 5: 1966-75.
20. Richter J, Wagner U, Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000; 157: 787-94.
21. Hsu FD, Nielsen TO, Alkushi A, et al. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 2002; 15: 1374-80.
22. Mengel M, von Wasielewski R, Wiese B, et al. Interlaboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 2002; 198: 292-9.